The Pharma Data

JULY 29, 2021

Takeda) and Frazier Healthcare Partners (Frazier) today announced a collaboration to launch HilleVax, Inc. Following our successful partnership to form Phathom Pharmaceuticals, we are extremely pleased to partner again with Takeda to form HilleVax,” said Tachi Yamada, M.D., co-founder of HilleVax and Venture Partner with Frazier.

Vaccination 52

Vaccination Vaccine Development Clinical Trials 52

Drug Discovery World

MARCH 15, 2024

The financing was jointly led by existing investors Pfizer Venture Investments, Sofinnova Partners, Roche Venture Fund, SR One, IP Group, and Rosetta Capital. Mission Therapeutics has raised £25.2 ($32.1)

Clinical Trials 52

Clinical Trials Clinical Trials In-Vivo Trials 52

Drug Discovery World

AUGUST 17, 2023

DDW’s Diana Spencer speaks to Alok Javali , CSO of dawn-bio, a new addition to BioInnovation Institute’s (BII) Venture Lab acceleration programme, about the lack of innovation in women’s reproductive health and the company’s plans to fill the vacuum. million in follow-up funding through BII’s Venture House programme.

Development 52

Development Drugs Medicine Business Development 52

pharmaphorum

OCTOBER 10, 2022

The digital health sphere reached the peak of its investment in 2021, with a total venture funding of $29.1 Investments surged following the pandemic, with investors having a supercharged interest in health tech, particularly telemedicine. Funding has been able to support a variety of different digital food allergy innovations.

Allergies 109

Allergies Marketing Doctors Doctor 109

XTalks

SEPTEMBER 27, 2023

This resulted in protein bread that contains three to six times more protein, about 30 percent fewer carbs and 50 percent less total sugar than other leading bread brands. The investor roster also includes kdT Ventures, 1derlife Partners, Accelr8 Partners and Axial Ventures.

Protein 59

Protein Branding Containment Production 59

The Pharma Data

JANUARY 5, 2021

The funds will help advance one of its drug candidates, CPV-101, to stages that will facilitate further investment from venture capitalists and/or pharmaceutical companies. This will enable additional investment from venture capital firms and/or pharmaceutical companies on the path to approval. About Eleva.

Drugs 52

Drugs Business Development Regulation Antibody 52

XTalks

MARCH 31, 2022

In this episode of the Xtalks Food Podcast, Sydney talks about TikTok’s influence on the food industry, from viral recipe videos to restaurant hacks. She explains how food and beverage brands can partner with content creators and engage in conversations on the app to maintain a social media presence.

Branding 52

Branding Protein Production Marketing 52

Drug Discovery World

JANUARY 22, 2024

The report reveals a robust sector with significant investment, the highest number of clinical trials in Europe, and NHS patients benefitting from these life-changing treatments. It reveals that UK companies secured 55% of Europe’s cell and gene therapy venture capital funding in 2023, showcasing the strength of the UK ecosystem.

Gene Therapy 52

Gene Therapy Gene Clinical Trials Clinical Trials 52

Drug Discovery World

MAY 22, 2023

Cell therapy, RNA technology, antibody drug conjugates and AI/machine learning are among the key areas of investment for pharma, according to a new report. billion and 493 private venture capital (VC) rounds that raised $22.2 The post Biopharma investment drops by nearly 50% in 2022 appeared first on Drug Discovery World (DDW).

RNA 52

RNA Pharma Companies Antibody Life Science 52

The Pharma Data

JANUARY 31, 2021

NASDAQ: ILMN), the global leader in DNA sequencing and array-based technologies, and Sequoia Capital China , a leading investment firm, today announced a collaboration to catalyze the startup ecosystem in China with the launch of the Sequoia Capital China Intelligent Healthcare Genomics Incubator, Powered by Illumina.

Genome 52

Genome Genomics Life Science DNA 52

The Pharma Data

DECEMBER 24, 2020

We are excited to work with Bonaventure Equity and have a partner who appreciates our rigorous standards.” ” Founded in 2014 by Ross O’Brien, Bonaventure Equity (“BVE”) is a boutique venture capital platform that provides capital, resources and unparalleled access to strategic and regulatory relationships.

Marketing 52

Marketing Scientist Manufacturing Development 52

The Pharma Data

OCTOBER 26, 2020

LONDON–( BUSINESS WIRE )– Prokarium , a privately-held biotechnology company developing novel immunotherapies and vaccines based on its engineered microbial platform, today announced the closing of a Series B investment round of $21M led by Korea Investment Partners (KIP). About Korea Investment Partners.

Engineer 52

Engineer Vaccination Vaccine Development 52

The Pharma Data

NOVEMBER 8, 2020

8, 2020 /PRNewswire/ — Inmagene Biopharmaceuticals (“Inmagene”), announced today that it had closed a $21 million Series B financing, led by Vertex Ventures China, and co-invested by Panacea Venture, Kunlun Capital, SCVC and a few other investors. About Inmagene Biopharmaceuticals. SHANGHAI , Nov.

Clinical Trials 40

Clinical Trials Clinical Trials Licensing Licensing 40

XTalks

APRIL 18, 2022

The burger is made in about six minutes, costs $6.99 Related: Tyson Ventures, Whole Foods’ Accelerator Program and Other Food Companies Investing in Innovation. “I RoboBurger is actively seeking retail partners in Greater Philadelphia and is looking to appeal to office workers who are starting to return to the city.

Containment 105

Containment Manufacturing Production Marketing 105

Drug Discovery World

JANUARY 23, 2024

The panel was moderated by Eleanor Malone (Citeline), and included Will Walker-Arnott (Charles Stanley), Rowan Gardner (PrecisionLife), Maina Bhaman (Sofinnova Partners), and Bradley Hardiman (Astellas Pharma). In this case, how should companies be going about raising funds? However, you cannot scale without investment.

Life Science 59

Life Science Business Development Protein Development 59

pharmaphorum

JANUARY 11, 2022

About Healthware Group. Proprietary software platforms, specialised media and educational assets as well as a corporate venturing arm, ensure accelerated product development, close integration within the innovation ecosystem, continuous pipeline development and superior market access capabilities.

Life Science 52

Life Science Production Branding Development 52

pharmaphorum

OCTOBER 8, 2021

The company’s founder and chief executive, Jahangir Mohammed, said that the system “lives alongside you, giving you a view into your beautifully complex biology, continuously learning about your metabolism and telling you what you can do to improve your health in the moment.”

Insulin 138

Insulin Pharma Companies Clinical Trials Clinical Trials 138

pharmaphorum

MARCH 23, 2022

Nucleai’s platform has been adapted from technology used to gather intelligence about military targets from geospatial data coming from satellite and high-altitude images, now applied to the mapping of biological microenvironments. Congrats @NucleaiMd on Series B financing —a warm welcome to the #SanofiVentures portfolio.

Doctors 52

Doctors Doctor Medicine Clinical Trials 52

pharmaphorum

MARCH 31, 2021

Fresh from a licensing agreement with Pfizer, US startup Pyxis Oncology has raised a sizeable $152 million in second-round financing led by venture capital groups Arix Bioscience and RTW Investments. .

Antibody 52

Antibody Licensing Licensing Drugs 52

pharmaphorum

APRIL 20, 2021

Roberto Ascione, Healthware Group’s CEO & Founder said: “ We are very excited about this acquisition, which further marks the commitment of Healthware in the next stage of evolution in learning science and advanced educational experiences. About Healthware Group. SWM Founders: Genevieve Robson and Francis Mahmud Namouk.

Life Science 98

Life Science Branding Marketing Development 98

Drug Discovery World

MARCH 13, 2024

Thanks to significant investment by the government into research and development, Singapore has become a leading centre for biomedical sciences in Asia. As a result, VCs have struggled to find sufficiently mature opportunities in which to invest.” Stephen Hess explains how the project will work: “65LAB offers up to US$1.5

Life Science 69

Life Science Genome Genomics Research 69

Drug Discovery World

MAY 11, 2023

DDW’s Megan Thomas spoke with attendees, and comments on the event. Fundraising and investment Coming out of a global pandemic, in-person events initially added a degree of novelty to networking. In his keynote, Tim Haines, Executive Partner at Abingworth, presented a path forward through the global economic uncertainty in the UK.

Life Science 52

Life Science Genetics Vaccination Vaccine 52

The Pharma Data

JANUARY 17, 2021

Sana’s initial investments came from Flagship Pioneering, ARCH Venture Partners, and F-Prime Capital. Of course, this is how biotech investments work. And once Phase II and Phase III clinical trials begin, the expenses add up fast and usually require either partnerships, IPOs or continued venture tranches.

In-Vivo 52

In-Vivo Marketing Engineer Genetics 52

pharmaphorum

FEBRUARY 14, 2022

In a recent report by Deloitte, however, the continual decline in return on R&D investment from 2014 was reversed in a minor way in 2020, followed by a significant improvement in 2021. As a result, the internal rate of return on investment is as high in 2021 as it has been across the industry since 2014. Continuing the progress.

Production 98

Production Clinical Trials Clinical Trials Sales 98

pharmaphorum

MAY 27, 2021

Ada Health has received another endorsement for its app to help patients diagnose conditions from symptoms, raising an impressive $90 million in funding from investors including the venture capital arm of Bayer. . Various health systems, insurers, life sciences companies, and other organisations are already using it.

Doctors 74

Doctors Doctor Life Science Marketing 74

XTalks

NOVEMBER 8, 2023

The strategic partnership, which brings Wonder Group a step further in its mission to streamline the dining experience, is anchored by Nestlé’s substantial $100 million investment. For Wonder Group, the investment is a pivotal move towards realizing its goal of making premium meals more accessible and convenient for consumers on the go.

Marketing 59

Marketing Medicine Production Development 59

pharmaphorum

JULY 4, 2022

David Weingard, chief impact officer of T1D Moonshot and founder of Cecelia Health, tells us how T1D Moonshot aims to break silos and advance type 1 diabetes prevention and treatment options by utilising numerous partners’ expertise. So, we thought hard about who to bring on,” Weingard says. In the US alone, 37.3

Life Science 104

Life Science Research Doctors Doctor 104

The Pharma Data

JULY 15, 2021

Lilly previously led an equity investment in Protomer alongside the JDRF T1D Fund, providing Lilly with 14 percent ownership of the company. Lilly is acquiring the remainder of the stock of Protomer beyond its initial investment. Aquilo Partners, L.P. Kirkland & Ellis LLP is serving as Lilly’s legal counsel.

Insulin 52

Insulin Protein Engineer Development 52

The Pharma Data

DECEMBER 9, 2020

It will if the following five companies, which all launched this year with Series A financing, have anything to say about it. . Vigil’s $50 million Series A financing, completed this week, was powered by Atlas Ventures and Northpond Ventures, and includes participating investors Hatteras Partners and Alexandria Venture Investments.

Marketing 52

Marketing In-Vivo Protein In-Vitro 52

The Pharma Data

JANUARY 27, 2021

As a clinician, healthcare administrator, biotech entrepreneur and venture capital investor, Steve’s leadership and breadth of experience in the clinical development of cell and gene therapies will be invaluable to PlateletBio as we progress our cell therapy platform into the clinic later this year,” said Sam Rasty, Ph.D., About PlateletBio.

Genetic Engineering 52

Genetic Engineering Gene Therapy Gene Engineer 52

Drug Discovery World

AUGUST 23, 2022

The funding was led by leading independent investment manager Albion Capital, which also included Octopus Ventures and Heal Capital.? . In order to ensure healthcare professionals are aware of the latest medicines, pharmaceutical companies must be provided with the latest data about them and their key focus areas.

Medicine 52

Medicine Marketing Drugs Development 52

The Pharma Data

JANUARY 18, 2021

Other investors included Sofinnova Investments, Longitude Capital, Fidelity Management & Research Company LLC, Surveyor Capital (a Citadel company), Octagon Capital, Kleiner Perkins , GV (formerly Google Ventures), and Alexandria Venture Investments. . SOUTH SAN FRANCISCO, Calif. ,

Development 52

Development Life Science Protein Clinical Development 52

pharmaphorum

DECEMBER 9, 2021

Heather Barnes, external innovation lead EMEA at Johnson and Johnson Consumer Health, is a scientist who is truly passionate about consumer health. JJDC also invested in a similarly named company called Rmdy that uses research backed ingredients to create consumer education-focused digestive health supplements.

Allergies 104

Allergies Life Science Development Scientist 104

pharmaphorum

APRIL 29, 2021

Founder and CEO Konstantin Mehl spoke to pharmaphorum’s news editor Richard Staines about why these treatments will be in demand as the world emerges from the pandemic. Digital health is ‘standard of care’ Last year saw record investment in digital health and according to a Rock Health report this continued into 2021, with $6.7

Production 67

Production Doctors Doctor Clinical Trials 67

The Pharma Data

DECEMBER 30, 2020

Today Ensysce announced that it has signed an agreement with GEM Global Yield LLC SCS, (GEM) a Luxembourg-based private, alternative investment group. About The GEM Group. billion alternative investment group based in Paris, New York and Los Angeles. Global Emerging Markets (“GEM”) is a $3.4

Marketing 52

Marketing Production Drugs Containment 52

The Pharma Data

JANUARY 24, 2021

chairman of the board of directors and partner at Third Rock Ventures. About Faze Medicines. He earned his B.Sc. in applied biochemistry from the University of Salford in Manchester, England and his Ph.D. in biochemistry from the University of Toronto in Ontario, Canada. For more information, visit fazemed.com. Source link.

Medicine 52

Medicine Pharma Companies Gene Therapy Development 52

XTalks

NOVEMBER 9, 2020

When you think about the taste of milk, a human mind would never think that a combination of pineapple and cabbage would recreate the taste of milk, but Giuseppe — our artificial intelligence — can and does,” said Matias Muchnick, founder and chief executive officer of NotCo, in a statement.

Protein 75

Protein Branding Containment Marketing 75